Shanghai INT Medical profit rises 22.68% to RMB 125.67 million in H1 FY26; revenue climbs 29.28% to RMB 596.06 millionPUBT·2 days ago, 08:14 AM01501+1.64%
Shanghai INT Medical Instruments files board, committee membership list for disclosure responsibilitiesPUBT·2 days ago, 08:12 AM01501+1.64%
Shanghai INT Medical names Chen Jie employee representative director after Wang resignsPUBT·2 days ago, 08:12 AM01501+1.64%
Shanghai INT Medical Instruments schedules board meeting on interim results, dividend considerationPUBT·Aug 12 at 03:44 AM01501+1.64%
Shanghai INT Medical Instruments announces extraordinary general meetingPUBT·Aug 10 at 04:05 AM01501+1.64%
Shanghai INT Medical Expands Stake in Target Firm via US$55 Million Indirect AcquisitionTip Ranks·Jul 23 at 09:38 AM01501+1.64%
Shanghai INT Medical buys 100% of Shanghai Maoyi for US$55.12 million, lifting Valgen stake to 27.82%PUBT·Jul 23 at 09:18 AM01501+1.64%
Shanghai INT Medical Grants Performance-Linked H-Share Awards to Executive DirectorTip Ranks·Jun 29 at 10:13 AM01501+1.64%
Shanghai INT Medical grants chairman Liang Dongke 33,400 H-share awards under trust schemePUBT·Jun 29 at 09:46 AM01501+1.64%
Shanghai INT Details Valuation and Compliance for Pulin Medical Stake AcquisitionTip Ranks·Jun 25 at 10:08 AM01501+1.64%
Shanghai INT Medical Instruments Raises Stake in Target Company via Second Discloseable AcquisitionTip Ranks·Jun 25 at 10:08 AM01501+1.64%
Shanghai INT Medical Completes Full Conversion to H Shares in Hong KongTip Ranks·Jun 3 at 03:39 AM01501+1.64%
Shanghai INT Medical Sets Formal Remuneration Committee MandateTip Ranks·May 28 at 07:39 PM01501+1.64%
Shanghai INT Medical Instruments Shareholders Unanimously Back 2025 Results and Dividend PlanTip Ranks·May 28 at 07:12 AM01501+1.64%
